There was a trend for increased risk of HCC among COVID-19+CLD group compared to COVID-19-CLD group (IRR: 1.19, 95%CI: 0.99-1.42, P = 0.06) but did not reach statistical significance.
← all excerpts
Effects of SARS-CoV-2 infection on incidence and treatment strategies of hepatocellular carcinoma in people with chronic liver disease.
1
—
—